46
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men

, , , , &
Pages 6453-6460 | Published online: 13 Aug 2019

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. doi:10.3322/caac.2144229313949
  • Attard G, Parker C, Eeles RA, et al. Prostate cancer. Lancet. 2016;387:70e82. doi:10.1016/S0140-6736(14)61947-426074382
  • Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–1092. doi:10.1016/j.eururo.2012.02.05422424666
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.2125425559415
  • Tosoian JJ, Ross AE, Sokoll LJ, Partin AW, Pavlovich CP. Urinary biomarkers for prostate cancer. Urol Clin North Am. 2016;43:17–38. doi:10.1016/j.ucl.2015.08.00326614026
  • Huang YQ, Sun T, Zhong WD, Wu CL. Clinical performance of serum [−2]proPSA derivatives, %p2PSA and phi, in the detection and management of prostate cancer. Am J Clin Exp Urol. 2014;2:343–350.25606581
  • Vukovic I, Djordjevic D, Bojanic N, Babic U, Soldatovic I. Predictive value of [−2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0 ng/mL PSA range. Int Braz J Urol. 2017;43(1):48–56. doi:10.1590/S1677-5538.IBJU.2016.025628124526
  • Al Saidi SS, Al Riyami NB, Al Marhoon MS, et al. Validity of prostate health index and percentage of [−2]pro-prostate-specific antigen as novel biomarkers in the diagnosis of prostate cancer: omani tertiary hospitals experience. Oman Med J. 2017;32(4):275–283. doi:10.5001/omj.2017.5528804579
  • Furuya K, Kawahara T, Narahara M, et al. Measurement of serum isoform [−2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2–10 ng/mL. Scand J Urol. 2017;51(4):251–257. doi:10.1080/21681805.2017.129815528351193
  • Lazzeri M, Briganti A, Scattoni V, et al. Serum index test %[−2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy. J Urol. 2012;188:1137–1143. doi:10.1016/j.juro.2012.06.01722901578
  • Na R, Ye DW, Qi J, et al. Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2–10 ng/mL and PSA >10 ng/mL: results from a Multicenter Study in China. Prostate. 2017;77(11):1221–1229. doi:10.1002/pros.23382
  • Sun WG, Liang CZ, Zheng QC, et al. Influence of age on seven putative prostate tumor markers: a cohort study in Chinese men. Asian J Androl. 2017;19:463–467. doi:10.4103/1008-682X.17578727048780
  • Lacher DA, Hughes JP. Total, free, and complexed prostate-specific antigen levels among US men, 2007–2010. Clin Chim Acta. 2015;448:220–227. doi:10.1016/j.cca.2015.06.00926093340
  • Rhodes T, Jacobson DJ, McGree ME, et al. Distribution and associations of[−2]proenzyme-prostate specific antigen in community dwelling black and white men. J Urol. 2012;187:92–96. doi:10.1016/j.juro.2011.09.01722093189
  • Dixon W. Processing data for ourliers. Biometrics. 1953;9:74–89. doi:10.2307/3001634
  • Reed AH, Henry RJ, Mason WB. Influence of statistical method used on the resulting estimate of normal range. Clin Chem. 1971;17:275–284.5552364
  • CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. 3rd ed. CLSI Document C28-A3c Wayne (PA): Clinical and Laboratory Standards Institute; 2008.
  • Liu ZY, Sun YH, Xu CL, et al. Age specific PSA reference ranges in Chinese men without prostate cancer. Asian J Androl. 2008;11:100–103. doi:10.1038/aja.2008.1719050693
  • Liu X, Wang J, Zhang S-X, Lin Q. Reference ranges of age-related prostatespecific antigen in men without cancer from Beijing area. Iran J Public Health. 2013;42:1216–1222.26171333
  • Choi H, Park JY, Shim JS, Kim JH, Bae JH. Free prostate-specific antigen provides more precise data on benign prostate volume than total prostate-specific antigen in korean population. Int Nenrourol J. 2013;17(2):73–77. doi:10.5213/inj.2013.17.2.73
  • Pereira J, Bilhim T, Duarte M, et al. Patient selection and counseling before prostatic arterial embolization. Tech Vasc Interv Radiol. 2012;15(4):270–275. doi:10.1053/j.tvir.2012.09.00323244723
  • Inci M, Rifaioglu MM, Inci M, et al. The investigation of total PSA, free PSA, and free/total PSA ratio in patients with liver cirrhosis patients according to Child-Pugh score. Urology. 2013;81(3):617–622. doi:10.1016/j.urology.2012.11.02223332995
  • Semjonow A, Köpke T, Eltze E, et al. Pre-analytical in-vitro stability of [−2]proPSA in blood and serum. Clin Biochem. 2010;43(10):926–928. doi:10.1016/j.clinbiochem.2010.04.06220450900